Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) reported first-quarter 2026 results and used its earnings call to highlight progress across its cell therapy pipeline, including its lead OpRegen program ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A cohort of patients treated with cell therapy showed ...
Annexon (NASDAQ:ANNX) President and CEO Doug Love outlined the company's late-stage pipeline and regulatory plans during a ...
All nine subjects of Phase 1 injected without any serious adverse events. Average improvement of 14.9 letters in visual acuity reported in the first six patients over a four-six month follow-up. Signs ...
Please provide your email address to receive an email when new articles are posted on . A study presented at Angiogenesis, Exudation, and Degeneration 2024 provided insights on how geographic atrophy ...
—Among patients diagnosed with intermediate-stage age-related macular degeneration, a fair number of eyes in a new analysis showed evidence of geographic atrophy (GA), a leading cause of blindness. It ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results